To evaluate the prognostic significance of IL13Rα2 in lung cancer, IL13Rα2 expression was examined via immunohistochemistry (IHC) analysis for 181 resected NSCLC patients. The gene discussed is IL13RA2; the disease is non-small cell lung carcinoma.